The soluble form of RAGE as a prognostic marker in melanoma

被引：0
|
作者：
Wagner, N. B. [1 ,2 ]
Petzinger, D. [1 ,2 ]
Lichtenberger, R. [1 ,2 ]
Holland-Letz, T. [3 ]
Findeisen, P. [4 ]
Umansky, V [1 ,2 ]
Utikal, J. [1 ,2 ]
Enk, A. H. [5 ]
Gebhardt, C. [1 ,2 ]
机构：
[1] German Canc Res Ctr, Skin Canc Unit, Heidelberg, Germany
[2] Univ Med Ctr Mannheim, Dept Dermatol, Mannheim, Germany
[3] German Canc Res Ctr, Dept Biostat, Heidelberg, Germany
[4] Univ Med Ctr Mannheim, Inst Clin Chem, Mannheim, Germany
[5] Univ Heidelberg Hosp, Dept Dermatol, Heidelberg, Germany
来源：
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT | 2013年 / 11卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：904 / 905
页数：2
相关论文
共 50 条
  • [1] The soluble form of RAGE (Receptor for advanced glycation end-products) as a prognostic marker in melanoma
    Wagner, N. B.
    Petzinger, D.
    Lichtenberger, R.
    Naeher, H.
    Holland-Letz, T.
    Findeisen, P.
    Umansky, V.
    Utikal, J.
    Enk, A. H.
    Gebhardt, C.
    EXPERIMENTAL DERMATOLOGY, 2013, 22 (03) : E43 - E43
  • [2] Soluble RAGE - a new diagnostic and prognostic early sepsis marker?
    Bopp, C.
    Hofer, S.
    Bierhaus, A.
    Martin, E.
    Weigand, M. A.
    INFECTION, 2007, 35 : 6 - 6
  • [3] Diminished levels of the soluble form of RAGE are related to poor survival in malignant melanoma
    Wagner, Nikolaus B.
    Weide, Benjamin
    Reith, Maike
    Tarnanidis, Kathrin
    Kehrel, Coretta
    Lichtenberger, Ramtin
    Pflugfelder, Annette
    Herpel, Esther
    Eubel, Jana
    Ikenberg, Kristian
    Busch, Christian
    Holland-Letz, Tim
    Naeher, Helmut
    Garbe, Claus
    Umansky, Viktor
    Enk, Alexander
    Utikal, Jochen
    Gebhardt, Christoffer
    INTERNATIONAL JOURNAL OF CANCER, 2015, 137 (11) : 2607 - 2617
  • [4] ECP as prognostic Marker for Melanoma
    Moreira, A.
    Krueckel, A.
    Schuler, G.
    Utikal, J.
    Heinzerling, L.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2019, 17 : 27 - 28
  • [5] XIAP as a prognostic marker for Malignant Melanoma
    Emanuel, PO
    Shafir, M
    Burstein, DE
    Mudgil, A
    Phelps, RG
    ANNALS OF SURGICAL ONCOLOGY, 2006, 13 (02) : 71 - 72
  • [6] Metallothioneins as a prognostic marker in primary melanoma
    Weinlich, G.
    Hassler, E.
    Baltaci, M.
    Eisendle, K.
    Fritsch, P.
    Zelger, B.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2006, 126 : S18 - S18
  • [7] Osteopontin as a molecular prognostic marker for melanoma
    Rangel, Javier
    Nosrati, Mehdi
    Torabian, Sima
    Shaikh, Ladan
    Leong, Stanley P. L.
    Haqq, Chris
    Miller, James R., III
    Sagebiel, Richard W.
    Kashani-Sabet, Mohammed
    CANCER, 2008, 112 (01) : 144 - 150
  • [8] Soluble RAGE as a Prognostic Marker of Worsening in Patients Admitted to the ICU for COVID-19 Pneumonia: A Prospective Cohort Study
    Besnier, Emmanuel
    Brunel, Valery
    Thill, Caroline
    Lepretre, Perrine
    Bellien, Jeremy
    Demailly, Zoe
    Renet, Sylvanie
    Tamion, Fabienne
    Clavier, Thomas
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (15)
  • [9] Soluble RAGE as a severity marker in community acquired pneumonia associated sepsis
    Rodrigo M Narvaez-Rivera
    Adrian Rendon
    Mario C Salinas-Carmona
    Adrian G Rosas-Taraco
    BMC Infectious Diseases, 12
  • [10] Soluble RAGE as a severity marker in community acquired pneumonia associated sepsis
    Narvaez-Rivera, Rodrigo M.
    Rendon, Adrian
    Salinas-Carmona, Mario C.
    Rosas-Taraco, Adrian G.
    BMC INFECTIOUS DISEASES, 2012, 12
12345